Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
FELDENE
Generic name / active ingredient
piroxicam oral capsules
Dosage-form class
Oral capsules. The dated FDA document lists two labelled strengths, 10 mg and 20 mg; different medicines, NSAIDs or market packs cannot be self-substituted, combined or used to select a tablet count from milligram figures alone.
Route
Oral
Record reviewed
2026-09-13

Copy from the pack in hand

Source-linked reading points

  • Do not self-combine, alternate or convert FELDENE with ibuprofen, naproxen, diclofenac, celecoxib, etoricoxib or aspirin merely because they are used for pain. The shared NSAID class instead signals a need to check duplication and risk first.
  • Prior ulcer or gastrointestinal bleeding, medicines affecting haemostasis, SSRI/SNRI medicines, ACE inhibitors/ARBs, diuretics, lithium, methotrexate and other NSAIDs on the same list require review against the complete list and exact product; the site does not generate spacing or stopping instructions.
  • The FDA Medication Guide warns that NSAIDs can cause serious cardiovascular and gastrointestinal adverse reactions. Older adults and people with cardiovascular disease, kidney disease, heart failure, dehydration or multiple medicines must not interpret a common pain medicine as permission to self-add it.
  • A name match cannot confirm capsule strength, an exact pack, authenticity or individual suitability. Check the actual pack, source date, prescription and complete medicine list together.

Reviewed presentation examples — compare every field

No exact presentation row has yet been published for this record. Use the pack and current target-market label.

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-13
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image